Journal article
In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
Abstract
SOURCE CITATION: Ortega-Paz L, Galli M, Capodanno D, et al. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J Cardiovasc Pharmacother. 2021. [Epub ahead of print.] 34519777.
Authors
Chaudhuri D; Rochwerg B
Journal
Annals of Internal Medicine, Vol. 175, No. 2,
Publisher
American College of Physicians
Publication Date
February 2022
DOI
10.7326/j21-0021
ISSN
1056-8751